Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic

被引:10
|
作者
Blaurock, Claudia [1 ]
Breithaupt, Angele [2 ]
Weber, Saskia [1 ]
Wylezich, Claudia [3 ]
Keller, Markus [1 ]
Mohl, Bjoern-Patrick [1 ]
Goerlich, Dirk [4 ]
Groschup, Martin H. [1 ]
Sadeghi, Balal [1 ]
Hoeper, Dirk [3 ]
Mettenleiter, Thomas C. [5 ]
Balkema-Buschmann, Anne [1 ]
机构
[1] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany
[2] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany
[3] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany
[4] Max Planck Inst Multidisciplinary Sci, Gottingen, Germany
[5] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany
关键词
D O I
10.1038/s41598-022-19222-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Golden Syrian hamsters (Mesocricetus auratus) are used as a research model for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Millions of Golden Syrian hamsters are also kept as pets in close contact to humans. To determine the minimum infective dose (MID) for assessing the zoonotic transmission risk, and to define the optimal infection dose for experimental studies, we orotracheally inoculated hamsters with SARS-CoV-2 doses from 1 * 10(5) to 1 * 10(-4) tissue culture infectious dose 50 (TCID50). Body weight and virus shedding were monitored daily. 1 * 10(-3) TCID50 was defined as the MID, and this was still sufficient to induce virus shedding at levels up to 10(2.75) TCID50/ml, equaling the estimated MID for humans. Virological and histological data revealed 1 * 10(2) TCID50 as the optimal dose for experimental infections. This compelling high susceptibility leading to productive infections in Golden Syrian hamsters must be considered as a potential source of SARS-CoV-2 infection for humans that come into close contact with pet hamsters.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Population Monitoring of SARS-CoV-2 Infections via Random Sampling During the COVID-19 Pandemic
    Elliott, Paul
    Ward, Helen
    Riley, Steven
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2023, 113 (05) : 514 - 516
  • [32] The role of SARS-CoV-2 aerosol transmission during the COVID-19 pandemic
    Tang, Julian W.
    Marr, Linsey C.
    Li, Yuguo
    Eames, Ian
    INTERFACE FOCUS, 2022, 12 (02)
  • [33] Lessons Learned during the Coronavirus – Covid-19 (SARS-CoV-2) Pandemic
    Bruzzese, Stacey L.
    Journal of Validation Technology, 2020, 26 (02)
  • [34] Otolaryngology Residency Application during the SARS-CoV-2 (COVID-19) Pandemic
    Quesada, Pompeyo R.
    Solis, Roberto N.
    Diaz, Rodney C.
    Kraft, Shannon M.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 163 (01) : 89 - 90
  • [35] COVID-19: ICU delirium management during SARS-CoV-2 pandemic
    Katarzyna Kotfis
    Shawniqua Williams Roberson
    Jo Ellen Wilson
    Wojciech Dabrowski
    Brenda T. Pun
    E. Wesley Ely
    Critical Care, 24
  • [36] Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
    Furnon, Wilhelm
    Cowton, Vanessa M.
    De Lorenzo, Giuditta
    Orton, Richard
    Herder, Vanessa
    Cantoni, Diego
    Ilia, Georgios
    Mendonca, Diogo Correa
    Kerr, Karen
    Allan, Jay
    Upfold, Nicole
    Meehan, Gavin R.
    Bakshi, Siddharth
    Das, Udeet Ranjan
    Arias, Sergi Molina
    Mcelwee, Marion
    Little, Sarah
    Logan, Nicola
    Kwok, Kirsty
    Smollett, Katherine
    Willett, Brian J.
    Filipe, Ana da Silva
    Robertson, David L.
    Grove, Joe
    Patel, Arvind H.
    Palmarini, Massimo
    NATURE MICROBIOLOGY, 2025, 10 (01): : 77 - 93
  • [37] Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic
    Dryden-Peterson, Scott
    Velasquez, Gustavo E.
    Stopka, Thomas J.
    Davey, Sonya
    Lockman, Shahin
    Ojikutu, Bisola O.
    JAMA NETWORK OPEN, 2021, 4 (02) : E2037067
  • [38] Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
    Abu-Raya, Bahaa
    Gantt, Soren
    Sadarangani, Manish
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (34) : E982 - E985
  • [39] COVID-19: ICU delirium management during SARS-CoV-2 pandemic
    Kotfis, Katarzyna
    Williams Roberson, Shawniqua
    Wilson, Jo Ellen
    Dabrowski, Wojciech
    Pun, Brenda T.
    Ely, E. Wesley
    CRITICAL CARE, 2020, 24 (01)
  • [40] Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 108